foxo4-dri senolytic peptide human trial 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Frontiers | Senolytic Peptide FOXO4-DRI

One compound of research interest is the human peptide GHK (glycyl-L-histidyl-L-lysine), a copper-binding peptide known for its diverse biological actions that have been studied in the context of aging-related diseases and conditions

Liver damage caused by cirrhosis or hepatitis can significantly increase the bioavailability of such drugs, resulting in high plasma levels and potential toxicity if the oral dose is not reduced

E7050: a dual c-met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models

Kratom ( Mitragyna Speciosa Korth.): A Description on the Ethnobotany, Alkaloid Chemistry, and Neuropharmacology, in Studies in Natural Products Chemistry

A possible contributor to this dichotomy of responses depends on the degree to which proximal neurons are injured